Clinicopathological features and prognosis of esophageal squamous cell carcinoma in young patients

• Published in: Diseases of the esophagus Vol. 32; no. 5
• Main Authors: Chen, S-B, Huang, S-J, Liu, D-T, Weng, H-R, Chen, Y-P
• Format: Journal Article
• Language: English
• Published: United States 01.05.2019
• Subjects: Adult; Age Factors; Aged; Aged, 80 and over; Combined Modality Therapy; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Esophageal Squamous Cell Carcinoma - secondary; Esophageal Squamous Cell Carcinoma - therapy; Esophagectomy; Family Health; Female; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prognosis; Survival Rate; Tumor Burden; clinicopathological features; esophageal squamous cell carcinoma; young patients; prognosis; survival
• ISSN: 1120-8694; 1442-2050
• DOI: 10.1093/dote/doy070

Esophageal squamous cell carcinoma (ESCC) in the young patients is comparatively rare and has not been well studied. We analyzed the clinical and survival data of 127 ESCC patients <40 years at a single high-volume center and compared with those of 4109 ESCC patients ≥40 years who underwent surgery within the same period in this study. The average age was 36.5 ± 0.2 years for the young patient group, with the youngest aged 26 years. Young patients had a higher rate of family history, longer tumors, and a more advanced pT category than their older counterparts. Moreover, more patients in the young group underwent incomplete resection (19.7% vs. 8.9%, P < 0.001) and adjuvant therapy (40.9% vs. 30.8%, P = 0.015). The overall survival (OS) and cancer-specific survival (CSS) between patients <40 years and patients ≥40 years were not significant in the entire group. In the subgroup analysis, the OS and CSS rates for patients <40 years were significantly worse than patients ≥40 years in subgroups of pTNM stage III and incomplete resections. In conclusions, young patients with ESCC were more likely to have family history and present with advanced disease. The survival for young patients with ESCC was poorer than their older counterparts in patients with later stage diseases.